Back
Arcutis Biotherapeutics Stock Price Chart
"The Next Apple?" - Mode's Growth Story is Turning Heads
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
39
ARQT
Arcutis Biotherapeutics
Last Price:
10.40
Seasonality Move:
-24.31%
7 Day Trial
ALL ACCESS PASS
$
7
32,481% Growth? Meet Mode Mobile's "EarnPhone"
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.- The current trend is moderately bullish and ARQT is experiencing buying pressure, which is a positive indicator for future bullish movement.
Arcutis Biotherapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 10.62 | Buy |
| 20-day SMA: | 10.06 | Buy |
| 50-day SMA: | 9.91 | Buy |
| 200-day SMA: | 8.03 | Buy |
| 8-day EMA: | 10.58 | Buy |
| 20-day EMA: | 10.27 | Buy |
| 50-day EMA: | 9.85 | Buy |
| 200-day EMA: | 8.91 | Buy |
Arcutis Biotherapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.33 | Buy |
| Relative Strength Index (14 RSI): | 56.93 | Buy |
| Chaikin Money Flow: | 835131 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (9.01 - 10.87) | Buy |
| Bollinger Bands (100): | (8.3 - 10.22) | Buy |
Arcutis Biotherapeutics Technical Analysis
| Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | Sep | |||||||||
| 30 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Arcutis Biotherapeutics Stock
Is Arcutis Biotherapeutics Stock a Buy?
- Arcutis Biotherapeutics share price is 10.66 while ARQT 8-day simple moving average is 10.62, which is a Buy signal.
- The stock price of ARQT is 10.66 while Arcutis Biotherapeutics 20-day SMA is 10.06, which makes it a Buy.
- Arcutis Biotherapeutics 50-day simple moving average is 9.91 while ARQT share price is 10.66, making it a Buy technically.
- ARQT stock price is 10.66 and Arcutis Biotherapeutics 200-day simple moving average is 8.03, creating a Buy signal.
ARQT Technical Analysis vs Fundamental Analysis
Sell
39
Arcutis Biotherapeutics (ARQT)
is a Sell
Is Arcutis Biotherapeutics a Buy or a Sell?
-
Arcutis Biotherapeutics stock is rated a Sell
The current Arcutis Biotherapeutics [ARQT] share price is $10.66. The Score for ARQT is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
Arcutis Biotherapeutics Stock Info
Market Cap:
1.25B
Price in USD:
10.66
Share Volume:
1.07M
Arcutis Biotherapeutics 52-Week Range
52-Week High:
13.17
52-Week Low:
1.76
Sell
39
Arcutis Biotherapeutics (ARQT)
is a Sell
Arcutis Biotherapeutics Share Price Forecast
-
What is the Arcutis Biotherapeutics stock price today?
The Arcutis Biotherapeutics stock price is 10.66 USD today. -
Will ARQT stock go up or go down?
Arcutis Biotherapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Arcutis Biotherapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Arcutis Biotherapeutics is overvalued.
Is Arcutis Biotherapeutics Stock a Buy?
- Arcutis Biotherapeutics share price is 10.66 while ARQT 8-day exponential moving average is 10.58, which is a Buy signal.
- The stock price of ARQT is 10.66 while Arcutis Biotherapeutics 20-day EMA is 10.27, which makes it a Buy.
- Arcutis Biotherapeutics 50-day exponential moving average is 9.85 while ARQT share price is 10.66, making it a Buy technically.
- ARQT stock price is 10.66 and Arcutis Biotherapeutics 200-day simple moving average is 8.91, creating a Buy signal.
Fundamental Analysis of Arcutis Biotherapeutics
Is Arcutis Biotherapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.50 per share, an increase next quarter of $0.17 per share, an increase this year of $2.44 per share, and an increase next year of $0.39 per share.
Technical Analysis of Arcutis Biotherapeutics
Should I short Arcutis Biotherapeutics stock?
- ARQT Moving Average Covergence Divergence (MACD) indicator is 0.33, suggesting Arcutis Biotherapeutics is a Buy
- Arcutis Biotherapeutics Relative Strength Index (RSI) is 56.93, which suggest Arcutis Biotherapeutics is overbought
- The Bollinger Bands (25) for Arcutis Biotherapeutics is (9.01 - 10.87), which suggest Arcutis Biotherapeutics is a Buy
- The Bollinger Bands (100) for Arcutis Biotherapeutics is (8.3 - 10.22), which suggest Arcutis Biotherapeutics is a Buy
* Arcutis Biotherapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.